Objective: To analyze the relationship between matrix Gla protein(MGP) and clinical characteristics of patients with ulcerative colitis (UC). Methods: Fifty-one UC patients who were admitted to the gastroenterology department of Peking union medical college hospital from July 1, 2015 to May 31, 2017 were included. Twenty-seven healthy subjects in the same period were included as normal controls. The expression of MGP mRNA in the colonic mucosa was detected by real-time fluorescence quantitative PCR. Clinical data of the patients were collected during a 2-year follow-up. The public data set containing MGP gene expression profile of UC patients was downloaded from the GEO database, and was divided into four groups according to the microscopic Mayo score. The differential expression of MGP in each group was analyzed. Results: All the fifty-one UC patients were followed up. The expression of MGP mRNA in the colonic mucosa of UC patients treated with hormone and immunosuppressive agents or biological agents or surgery was higher than that of patients treated with mesalazine. MGP mRNA expression was positively correlated with C-reactive protein level. It was also higher in the colonic mucosa of UC patients with clostridium difficilis or cytomegalovirus infection than that of patients without opportunistic infection. The difference of MGP mRNA expression between groups in GEO public data set was statistically significant(P<0.01), showing an up-regulation trend with the aggravation of inflammation. The expression level of MGP was moderately correlated with the microscopic Mayo score. The relationship between MGP mRNA expression and lifestyle, lesion range, erythrocyte sedimentation rate, parenteral manifestations and recurrence frequency of UC patients was not obvious. Conclusions: MGP is associated with colonic inflammation and its abnormal expression can help to predict the disease activity of patients with UC.
目的: 分析基质Gla蛋白(MGP)与溃疡性结肠炎(UC)患者临床特征之间的关系。 方法: 纳入2015年7月1日至2017年5月31日期间在北京协和医院消化内科就诊的UC患者51例,以及同时期健康体检者27例,采用实时荧光定量PCR检测其结肠黏膜中MGP mRNA的表达,收集患者的临床资料,并进行随访。从GEO数据库中下载包含有UC患者MGP基因表达谱的公共数据集,按照内镜下Mayo评分分为Mayo 0、1、2、3分4个组。分析MGP在各组间差异表达情况。 结果: 纳入的所有UC患者完成随访,随访中位时间23个月(17~53个月)。UC活动组中MGP mRNA的表达高于缓解组和对照组。使用糖皮质激素及免疫抑制剂或生物制剂、手术治疗的UC患者,其结肠黏膜中MGP mRNA表达量高于使用美沙拉嗪治疗的患者。UC患者结肠黏膜MGP mRNA表达量与炎症指标C反应蛋白水平呈正相关(r=0.517)。合并难辨梭菌或巨细胞病毒感染的UC患者结肠黏膜中MGP mRNA表达量高于无机会性感染的患者。GEO公共数据集中MGP在各组间表达差异有统计学意义(P<0.01),随炎症程度加重MGP表达逐渐增加。组织MGP表达水平与内镜下Mayo评分存在中度相关。MGP mRNA表达与UC患者的生活方式、病变范围、肠外表现、随访期间有无复发的关系不明显。 结论: MGP与UC患者结肠炎症有关,其表达异常可以帮助预测UC患者病情活动度。.
Keywords: Clinical features; Matrix Gla protein; Ulcerative colitis.